Personalized Treatment Plan: Based on your unique needs and goals, well select the most appropriate weight loss medication and design a tailored treatment plan
Both B12 shots and IV infusions bypass the gastrointestinal tract entirely, eliminating this dose-dependent absorption loss
Active medical weight loss treatment isnt recommended at this stage
Full disclaimer 1.AOD-9604 is a 16-amino acid peptide fragment derived from human growth hormone (hGH residues 177-191) with added tyrosine, developed by Metabolic Pharmaceuticals for obesity treatment 2.Proposed mechanism: selective stimulation of lipolysis (fat breakdown) and inhibition of lipogenesis (fat formation) without growth hormone-like effects on IGF-1 or blood glucose 3.Failed Phase 2b clinical trial for obesity (2007)did not demonstrate statistically significant weight loss versus placebo, terminating clinical development for this indication 4.Received FDA "Generally Recognized as Safe" (GRAS) designation in 2023 as a food substance, but this is NOT a drug approval and does not establish efficacy for weight loss 5.Regulatory status: not FDA-approved as a drug, prohibited by WADA, and insufficient evidence for weight loss efficacy

How Retatrutide Works: The Triple-Action Engine Retatrutide, known in the lab as LY3437943, is a fatty-acid-acylated single peptide engineered to switch on three receptors that all play a role in metabolism
Single cells were either identified by selecting coherent regions in a certain range of size or by using the ROIs earlier defined by Cellpose